TACROLIMUS EXTENDED-RELEASE CAPSULES

TACROLIMUS EXTENDED-RELEASE CAPSULES was reported 127607 times

These side effects are most commonly reported by patients taking TACROLIMUS EXTENDED-RELEASE CAPSULES:

# Side effect Count
0 OFF LABEL USE 13196
1 DRUG INEFFECTIVE 9055
2 PRODUCT USE IN UNAPPROVED INDICATION 6165
3 DRUG INTERACTION 5630
4 ACUTE KIDNEY INJURY 5530
5 DIARRHOEA 4599
6 TRANSPLANT REJECTION 4151
7 CYTOMEGALOVIRUS INFECTION 4081
8 PYREXIA 3881
9 COVID-19 3756
10 TOXICITY TO VARIOUS AGENTS 3720
11 PNEUMONIA 3651
12 DEATH 3467
13 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2975
14 SEPSIS 2944
15 RENAL IMPAIRMENT 2892
16 CONDITION AGGRAVATED 2781
17 NAUSEA 2529
18 THROMBOTIC MICROANGIOPATHY 2495
19 RESPIRATORY FAILURE 2472
20 ANAEMIA 2317
21 SEPTIC SHOCK 2296
22 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2289
23 VOMITING 2235
24 BLOOD CREATININE INCREASED 2210
25 NEUTROPENIA 2152
26 URINARY TRACT INFECTION 2136
27 RENAL FAILURE 2082
28 INFECTION 2012
29 DYSPNOEA 1992
30 HEADACHE 1988
31 FATIGUE 1968
32 RASH 1922
33 LEUKOPENIA 1911
34 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1875
35 HYPERTENSION 1857
36 PRURITUS 1827
37 THROMBOCYTOPENIA 1812
38 KIDNEY TRANSPLANT REJECTION 1760
39 PANCYTOPENIA 1736
40 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1736
41 CYTOMEGALOVIRUS VIRAEMIA 1718
42 EPSTEIN-BARR VIRUS INFECTION 1534
43 ABDOMINAL PAIN 1530
44 DRUG LEVEL INCREASED 1528
45 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1480
46 GRAFT VERSUS HOST DISEASE 1427
47 BK VIRUS INFECTION 1419
48 WEIGHT DECREASED 1359
49 ASPERGILLUS INFECTION 1308
50 NEPHROPATHY TOXIC 1288
51 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1285
52 BRONCHOPULMONARY ASPERGILLOSIS 1256
53 PAIN 1245
54 COUGH 1244
55 ASTHENIA 1236
56 CYTOMEGALOVIRUS INFECTION REACTIVATION 1217
57 TREMOR 1198
58 PNEUMOCYSTIS JIROVECII PNEUMONIA 1188
59 FEBRILE NEUTROPENIA 1187
60 COMPLICATIONS OF TRANSPLANTED KIDNEY 1129
61 PLEURAL EFFUSION 1127
62 TREATMENT FAILURE 1124
63 HYPOTENSION 1121
64 ACUTE GRAFT VERSUS HOST DISEASE 1108
65 PRODUCT USE ISSUE 1105
66 CHRONIC KIDNEY DISEASE 1091
67 DISEASE PROGRESSION 1088
68 DISEASE RECURRENCE 1086
69 DIABETES MELLITUS 1084
70 MALAISE 1078
71 ACUTE RESPIRATORY DISTRESS SYNDROME 1028
72 MATERNAL EXPOSURE DURING PREGNANCY 1027
73 STAPHYLOCOCCAL INFECTION 1026
74 DERMATITIS ATOPIC 1023
75 DECREASED APPETITE 987
76 FUNGAL INFECTION 983
77 PSEUDOMONAS INFECTION 972
78 CHRONIC GRAFT VERSUS HOST DISEASE 970
79 ARTHRALGIA 960
80 NOCARDIOSIS 954
81 HYPERKALAEMIA 947
82 KLEBSIELLA INFECTION 944
83 FOETAL EXPOSURE DURING PREGNANCY 934
84 TRANSPLANT DYSFUNCTION 919
85 EXPOSURE DURING PREGNANCY 911
86 ADENOVIRUS INFECTION 896
87 DRUG RESISTANCE 895
88 ENTEROCOCCAL INFECTION 894
89 ESCHERICHIA INFECTION 888
90 HAEMOGLOBIN DECREASED 887
91 NEUROTOXICITY 881
92 ERYTHEMA 869
93 KAPOSI^S SARCOMA 868
94 BACTERAEMIA 832
95 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 821
96 DEHYDRATION 815
97 DIZZINESS 814
98 PROTEINURIA 811
99 CANDIDA INFECTION 810
100 DRUG INTOLERANCE 801
101 ENCEPHALOPATHY 799
102 PREMATURE BABY 797
103 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 790
104 THERAPY NON-RESPONDER 782
105 MUCORMYCOSIS 779
106 DRY SKIN 769
107 LIVER TRANSPLANT REJECTION 769
108 GASTROINTESTINAL DISORDER 763
109 DIFFUSE LARGE B-CELL LYMPHOMA 756
110 TRANSPLANT FAILURE 748
111 RENAL TUBULAR NECROSIS 727
112 HOSPITALISATION 717
113 POLYOMAVIRUS VIRAEMIA 716
114 CARDIAC ARREST 708
115 COLITIS 707
116 ASCITES 704
117 PRODUCT DOSE OMISSION ISSUE 704
118 END STAGE RENAL DISEASE 702
119 COVID-19 PNEUMONIA 698
120 INTERSTITIAL LUNG DISEASE 689
121 TUBULOINTERSTITIAL NEPHRITIS 687
122 BACTERIAL INFECTION 680
123 ECZEMA 678
124 GRAFT VERSUS HOST DISEASE IN SKIN 678
125 HERPES ZOSTER 677
126 CONFUSIONAL STATE 672
127 INTENTIONAL PRODUCT USE ISSUE 664
128 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 648
129 METABOLIC ACIDOSIS 646
130 GASTROINTESTINAL HAEMORRHAGE 643
131 WEIGHT INCREASED 641
132 PLATELET COUNT DECREASED 639
133 FALL 633
134 SEIZURE 628
135 OEDEMA PERIPHERAL 622
136 PREMATURE DELIVERY 619
137 ABDOMINAL PAIN UPPER 615
138 ALOPECIA 607
139 INFLUENZA 601
140 SKIN EXFOLIATION 601
141 HEPATIC FAILURE 592
142 GENERAL PHYSICAL HEALTH DETERIORATION 588
143 HYPERGLYCAEMIA 582
144 ACUTE RESPIRATORY FAILURE 577
145 VENOOCCLUSIVE LIVER DISEASE 577
146 PAIN IN EXTREMITY 567
147 MUCOSAL INFLAMMATION 561
148 LYMPHOPENIA 560
149 SQUAMOUS CELL CARCINOMA OF SKIN 552
150 INSOMNIA 543
151 RENAL TRANSPLANT FAILURE 543
152 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 540
153 CHILLS 537
154 RENAL DISORDER 534
155 HYPONATRAEMIA 532
156 CHEST PAIN 531
157 PARVOVIRUS B19 INFECTION 530
158 TACHYCARDIA 530
159 CARDIAC FAILURE 528
160 HYPOXIA 525
161 RESPIRATORY DISTRESS 525
162 CLOSTRIDIUM DIFFICILE INFECTION 517
163 CYTOMEGALOVIRUS COLITIS 516
164 HYPOGAMMAGLOBULINAEMIA 516
165 ATRIAL FIBRILLATION 511
166 MENTAL STATUS CHANGES 510
167 SKIN LESION 508
168 ALANINE AMINOTRANSFERASE INCREASED 501
169 HEART TRANSPLANT REJECTION 499
170 LYMPHADENOPATHY 499
171 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 499
172 OVERDOSE 497
173 PULMONARY EMBOLISM 496
174 BACK PAIN 491
175 MYALGIA 491
176 CELLULITIS 486
177 DELAYED GRAFT FUNCTION 486
178 EPSTEIN-BARR VIRAEMIA 486
179 LOW BIRTH WEIGHT BABY 484
180 ABDOMINAL DISCOMFORT 483
181 HERPES SIMPLEX 482
182 BRAIN ABSCESS 478
183 BLOOD PRESSURE INCREASED 476
184 CLOSTRIDIUM DIFFICILE COLITIS 475
185 PYELONEPHRITIS 473
186 PNEUMONIA BACTERIAL 471
187 CYSTITIS HAEMORRHAGIC 469
188 HAEMORRHAGE 468
189 CRYPTOCOCCOSIS 466
190 CHRONIC ALLOGRAFT NEPHROPATHY 465
191 PATHOGEN RESISTANCE 465
192 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 461
193 HEPATIC FUNCTION ABNORMAL 460
194 PERICARDIAL EFFUSION 460
195 SQUAMOUS CELL CARCINOMA 458
196 VIRAL INFECTION 458
197 INJECTION SITE PAIN 456
198 THERAPEUTIC RESPONSE DECREASED 448
199 CONSTIPATION 446
200 KIDNEY FIBROSIS 444
201 HEPATITIS C 441
202 WHITE BLOOD CELL COUNT DECREASED 440
203 HEPATIC ENZYME INCREASED 437
204 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 433
205 GAIT DISTURBANCE 433
206 TREATMENT NONCOMPLIANCE 433
207 MUSCULAR WEAKNESS 432
208 ANXIETY 429
209 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 428
210 BLOOD GLUCOSE INCREASED 427
211 PSORIASIS 425
212 PULMONARY NOCARDIOSIS 424
213 STOMATITIS 423
214 DISSEMINATED INTRAVASCULAR COAGULATION 420
215 RENAL FAILURE ACUTE 417
216 HEPATITIS E 416
217 HAEMATURIA 415
218 THERAPY PARTIAL RESPONDER 415
219 UPPER RESPIRATORY TRACT INFECTION 413
220 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 412
221 PNEUMONIA CYTOMEGALOVIRAL 411
222 DEEP VEIN THROMBOSIS 410
223 PULMONARY OEDEMA 409
224 BONE MARROW FAILURE 408
225 SHOCK 408
226 CYTOPENIA 405
227 INCORRECT DOSE ADMINISTERED 403
228 COLITIS ULCERATIVE 401
229 MULTI-ORGAN FAILURE 401
230 PERIPHERAL SWELLING 401
231 NEUROPATHY PERIPHERAL 399
232 DEPRESSION 397
233 MALACOPLAKIA 397
234 RESPIRATORY TRACT INFECTION 397
235 MENINGITIS CRYPTOCOCCAL 396
236 VARICELLA ZOSTER VIRUS INFECTION 395
237 APLASIA PURE RED CELL 394
238 DYSPHAGIA 392
239 INFLAMMATION 391
240 ASPARTATE AMINOTRANSFERASE INCREASED 388
241 THROMBOSIS 388
242 SINUSITIS 387
243 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 386
244 DRUG LEVEL DECREASED 386
245 OEDEMA 386
246 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 382
247 HYDRONEPHROSIS 382
248 HISTOPLASMOSIS DISSEMINATED 379
249 STRONGYLOIDIASIS 377
250 DIABETIC KETOACIDOSIS 376
251 CEREBROVASCULAR ACCIDENT 375
252 PHAEOHYPHOMYCOSIS 372
253 PNEUMATOSIS INTESTINALIS 370
254 SOMNOLENCE 369
255 NASOPHARYNGITIS 368
256 JC VIRUS INFECTION 366
257 TRANSAMINASES INCREASED 366
258 UROSEPSIS 365
259 VISION BLURRED 364
260 PNEUMONIA FUNGAL 363
261 ABDOMINAL DISTENSION 360
262 CROHN^S DISEASE 359
263 C-REACTIVE PROTEIN INCREASED 358
264 LIVER FUNCTION TEST ABNORMAL 358
265 HUMAN HERPESVIRUS 6 INFECTION 357
266 BASAL CELL CARCINOMA 355
267 URTICARIA 355
268 VISUAL IMPAIRMENT 353
269 MYELOSUPPRESSION 350
270 CEREBRAL HAEMORRHAGE 348
271 PULMONARY MASS 348
272 SHOCK HAEMORRHAGIC 348
273 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 343
274 NEOPLASM MALIGNANT 342
275 PANCREATITIS ACUTE 342
276 RENAL TUBULAR INJURY 342
277 INFECTION REACTIVATION 341
278 MOUTH ULCERATION 341
279 PERITONITIS 340
280 DISCOMFORT 338
281 DEVICE RELATED INFECTION 336
282 NEPHROTIC SYNDROME 336
283 SWELLING 335
284 SMOOTH MUSCLE CELL NEOPLASM 334
285 LIVER DISORDER 333
286 HYPOMAGNESAEMIA 329
287 ENCEPHALITIS 327
288 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 326
289 DRUG LEVEL ABOVE THERAPEUTIC 325
290 SPLENOMEGALY 325
291 HUMAN HERPESVIRUS 8 INFECTION 324
292 PANCREATITIS 322
293 PNEUMONITIS 321
294 HYPERSENSITIVITY 320
295 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 318
296 ORGANISING PNEUMONIA 318
297 GASTROENTERITIS 316
298 VIRAEMIA 315
299 CHOLESTASIS 312
300 FUNGAL SKIN INFECTION 308
301 OSTEOMYELITIS 308
302 CYTOMEGALOVIRUS TEST POSITIVE 307
303 STENOTROPHOMONAS INFECTION 305
304 GRAFT LOSS 304
305 ACUTE MYELOID LEUKAEMIA 303
306 HUMAN POLYOMAVIRUS INFECTION 303
307 TRICHODYSPLASIA SPINULOSA 303
308 HEPATOTOXICITY 302
309 COMA 300
310 DRY EYE 300
311 GASTRIC ULCER 298
312 DRUG-INDUCED LIVER INJURY 297
313 LOSS OF CONSCIOUSNESS 297
314 BLOOD BILIRUBIN INCREASED 296
315 DRUG HYPERSENSITIVITY 296
316 LEUKOCYTOSIS 296
317 ABORTION SPONTANEOUS 295
318 ACTINIC KERATOSIS 294
319 CEREBRAL INFARCTION 294
320 HAEMATOCHEZIA 294
321 BLOOD UREA INCREASED 292
322 BRAIN OEDEMA 292
323 LUNG DISORDER 292
324 SLEEP DISORDER 290
325 ELECTROLYTE IMBALANCE 289
326 PRODUCTIVE COUGH 289
327 SYSTEMIC MYCOSIS 288
328 ESCHERICHIA URINARY TRACT INFECTION 286
329 HYPOALBUMINAEMIA 286
330 MYOCARDIAL INFARCTION 286
331 MUSCLE SPASMS 285
332 HAEMOLYTIC URAEMIC SYNDROME 284
333 ACUTE HEPATIC FAILURE 282
334 TUBERCULOSIS 282
335 HYPERCALCAEMIA 280
336 RHEUMATOID ARTHRITIS 279
337 SKIN ULCER 279
338 DYSURIA 278
339 ACNE 277
340 ELECTROCARDIOGRAM QT PROLONGED 276
341 RENAL TUBULAR ATROPHY 276
342 RASH ERYTHEMATOUS 275
343 NEPHROPATHY 274
344 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 274
345 SCEDOSPORIUM INFECTION 272
346 ANURIA 270
347 STAPHYLOCOCCAL BACTERAEMIA 267
348 HYPOKALAEMIA 265
349 OSTEONECROSIS 264
350 CHOLANGITIS 263
351 FEELING ABNORMAL 263
352 GASTROOESOPHAGEAL REFLUX DISEASE 263
353 BRONCHITIS 262
354 HAEMOPTYSIS 260
355 PARAESTHESIA 260
356 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 259
357 LACTIC ACIDOSIS 257
358 BACTERIAL SEPSIS 256
359 DELIRIUM 256
360 NO ADVERSE EVENT 256
361 GENERALISED TONIC-CLONIC SEIZURE 255
362 HEPATOCELLULAR CARCINOMA 255
363 LUNG INFECTION 255
364 SYSTEMIC CANDIDA 254
365 HAEMOLYTIC ANAEMIA 253
366 LYMPHOPROLIFERATIVE DISORDER 253
367 OLIGURIA 253
368 ANAPHYLACTIC REACTION 251
369 DYSPEPSIA 249
370 LUNG TRANSPLANT REJECTION 249
371 RENAL INJURY 249
372 PHOTOSENSITIVITY REACTION 247
373 OROPHARYNGEAL PAIN 246
374 PNEUMOTHORAX 245
375 ENTEROBACTER INFECTION 244
376 HISTOPLASMOSIS 244
377 PULMONARY MUCORMYCOSIS 243
378 CATARACT 241
379 HAEMATOMA 241
380 HAEMORRHAGE INTRACRANIAL 241
381 HYPOAESTHESIA 241
382 IMMUNOSUPPRESSION 241
383 EYE PAIN 240
384 RESPIRATORY SYNCYTIAL VIRUS INFECTION 240
385 DEPRESSED LEVEL OF CONSCIOUSNESS 239
386 OSTEOPOROSIS 239
387 APLASTIC ANAEMIA 238
388 PULMONARY ALVEOLAR HAEMORRHAGE 238
389 HEART RATE INCREASED 237
390 HAEMODYNAMIC INSTABILITY 236
391 OXYGEN SATURATION DECREASED 236
392 RENAL TRANSPLANT 236
393 WEST NILE VIRAL INFECTION 236
394 COAGULOPATHY 235
395 MYCOBACTERIAL INFECTION 235
396 PNEUMOCYSTIS JIROVECII INFECTION 235
397 ALTERNARIA INFECTION 234
398 IMPAIRED HEALING 233
399 GLOMERULONEPHRITIS 232
400 TOXOPLASMOSIS 232
401 ASTHMA 231
402 HEPATITIS 231
403 SKIN INFECTION 231
404 DISSEMINATED CRYPTOCOCCOSIS 230
405 BLOOD LACTATE DEHYDROGENASE INCREASED 229
406 ILLNESS 227
407 MEMORY IMPAIRMENT 227
408 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 226
409 LOWER RESPIRATORY TRACT INFECTION 226
410 CONTUSION 224
411 ENDOPHTHALMITIS 224
412 RHINOVIRUS INFECTION 224
413 THERAPY INTERRUPTED 223
414 VIRAL HAEMORRHAGIC CYSTITIS 223
415 ESCHERICHIA BACTERAEMIA 222
416 BLOOD POTASSIUM INCREASED 220
417 WHITE BLOOD CELL COUNT INCREASED 220
418 ADVERSE DRUG REACTION 219
419 HEMIPARESIS 219
420 APHASIA 218
421 DERMATITIS 218
422 FLUID RETENTION 218
423 METASTASES TO LUNG 218
424 ORAL HERPES 218
425 CRYPTOSPORIDIOSIS INFECTION 217
426 NERVOUS SYSTEM DISORDER 217
427 PNEUMONIA KLEBSIELLA 217
428 SKIN FISSURES 217
429 DISSEMINATED TUBERCULOSIS 216
430 RESPIRATORY DISORDER 216
431 CYTOMEGALOVIRUS CHORIORETINITIS 215
432 EYE IRRITATION 215
433 BRADYCARDIA 214
434 PRE-ECLAMPSIA 214
435 VENOOCCLUSIVE DISEASE 214
436 GLOMERULAR FILTRATION RATE DECREASED 213
437 LYMPHOCYTE COUNT DECREASED 213
438 PNEUMONIA ASPIRATION 213
439 AUTOIMMUNE HAEMOLYTIC ANAEMIA 212
440 CHEST DISCOMFORT 212
441 SWELLING FACE 212
442 FOETAL GROWTH RESTRICTION 211
443 JAUNDICE 211
444 MYOPATHY 211
445 ACUTE MYELOID LEUKAEMIA RECURRENT 210
446 BLOOD ALKALINE PHOSPHATASE INCREASED 210
447 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 210
448 PNEUMONIA PSEUDOMONAL 210
449 BLASTOMYCOSIS 208
450 BLINDNESS 208
451 DYSARTHRIA 208
452 ABSCESS 207
453 GASTRITIS 207
454 LETHARGY 207
455 DYSPNOEA EXERTIONAL 206
456 RHABDOMYOLYSIS 205
457 PLASMA CELL MYELOMA 204
458 RASH PRURITIC 203
459 URINE OUTPUT DECREASED 203
460 HYPERAMMONAEMIA 202
461 WOUND INFECTION 202
462 CYSTITIS 201
463 SKIN CANCER 201
464 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 200
465 SYSTEMIC LUPUS ERYTHEMATOSUS 200
466 INTESTINAL OBSTRUCTION 199
467 PULMONARY HYPERTENSION 199
468 PALPITATIONS 198
469 SYNCOPE 198
470 ATELECTASIS 197
471 CARDIO-RESPIRATORY ARREST 197
472 ENDOCARDITIS 197
473 HYPERBILIRUBINAEMIA 197
474 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 196
475 CARDIAC FAILURE CONGESTIVE 196
476 HEPATITIS B 196
477 HYPOPHAGIA 196
478 HEPATIC CIRRHOSIS 194
479 OVARIAN CYST 194
480 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 193
481 AGRANULOCYTOSIS 193
482 OCULAR HYPERAEMIA 193
483 RENAL TUBULAR ACIDOSIS 193
484 AGITATION 192
485 GASTROENTERITIS NOROVIRUS 192
486 NOROVIRUS INFECTION 192
487 STATUS EPILEPTICUS 192
488 INFUSION RELATED REACTION 191
489 NECROSIS 191
490 STAPHYLOCOCCAL SEPSIS 191
491 ENTERITIS 190
492 PRODUCT PRESCRIBING ISSUE 190
493 CARDIOGENIC SHOCK 189
494 MYCOBACTERIUM AVIUM COMPLEX INFECTION 189
495 BURNING SENSATION 188
496 MELAENA 188
497 PSYCHOTIC DISORDER 187
498 ALTERED STATE OF CONSCIOUSNESS 186
499 GUILLAIN-BARRE SYNDROME 186
500 ORAL CANDIDIASIS 186
501 CONVULSION 185
502 PNEUMONIA CRYPTOCOCCAL 185
503 LUNG INFILTRATION 184
504 VERTIGO 184
505 EPISTAXIS 183
506 RENAL GRAFT INFECTION 183
507 IGA NEPHROPATHY 182
508 POSTOPERATIVE WOUND INFECTION 182
509 DIVERTICULITIS 181
510 DYSLIPIDAEMIA 181
511 INFLAMMATORY BOWEL DISEASE 181
512 MALNUTRITION 181
513 MYELODYSPLASTIC SYNDROME 181
514 OESOPHAGITIS 181
515 RED BLOOD CELL COUNT DECREASED 181
516 SURGERY 181
517 ACUTE MYOCARDIAL INFARCTION 180
518 HAEMOLYSIS 180
519 OESOPHAGEAL CANDIDIASIS 180
520 URINARY TRACT INFECTION BACTERIAL 180
521 KIDNEY INFECTION 179
522 NEPHROLITHIASIS 179
523 BLOOD PRESSURE DECREASED 178
524 DISSEMINATED MUCORMYCOSIS 178
525 ACINETOBACTER INFECTION 177
526 BLISTER 177
527 ENTEROCOLITIS 177
528 FOOD ALLERGY 177
529 LUNG CONSOLIDATION 177
530 ACIDOSIS 176
531 REBOUND EFFECT 176
532 DIPLOPIA 175
533 HYPERHIDROSIS 175
534 HYPOGLYCAEMIA 175
535 CARDIAC DISORDER 174
536 GRAFT VERSUS HOST DISEASE IN LIVER 174
537 SUBARACHNOID HAEMORRHAGE 174
538 DRUG LEVEL BELOW THERAPEUTIC 173
539 LIVER ABSCESS 173
540 MALIGNANT NEOPLASM PROGRESSION 173
541 SECONDARY IMMUNODEFICIENCY 173
542 VISUAL ACUITY REDUCED 173
543 CONJUNCTIVITIS 172
544 RASH MACULO-PAPULAR 172
545 SMALL INTESTINAL OBSTRUCTION 171
546 CEREBRAL TOXOPLASMOSIS 170
547 KLEBSIELLA BACTERAEMIA 170
548 OBLITERATIVE BRONCHIOLITIS 170
549 THERAPEUTIC RESPONSE SHORTENED 170
550 CENTRAL NERVOUS SYSTEM LESION 169
551 BOWEN^S DISEASE 168
552 CYTOKINE RELEASE SYNDROME 168
553 DISORIENTATION 168
554 ENCEPHALITIS VIRAL 168
555 LIVER FUNCTION TEST INCREASED 168
556 ALVEOLAR PROTEINOSIS 167
557 LIVER INJURY 167
558 LYMPHOCELE 167
559 VACCINATION FAILURE 167
560 ARTERIOSCLEROSIS 166
561 PULMONARY HAEMORRHAGE 166
562 HAEMATOCRIT DECREASED 165
563 HYPOTHYROIDISM 165
564 LARGE INTESTINE PERFORATION 165
565 LYMPHOMA 165
566 SKIN HAEMORRHAGE 165
567 ESCHERICHIA SEPSIS 164
568 JOINT SWELLING 164
569 METASTASES TO LIVER 164
570 PAPILLOMA VIRAL INFECTION 163
571 HEPATIC FIBROSIS 162
572 PNEUMOMEDIASTINUM 162
573 RHINORRHOEA 162
574 SCLERODERMA 162
575 TACHYPNOEA 162
576 EYE PRURITUS 161
577 EPILEPSY 160
578 GAMMA-GLUTAMYLTRANSFERASE INCREASED 160
579 SKIN DISCOLOURATION 160
580 URINARY RETENTION 160
581 INTESTINAL PERFORATION 159
582 OESOPHAGEAL ULCER 159
583 PULMONARY TUBERCULOSIS 159
584 SKIN DISORDER 159
585 SKIN PAPILLOMA 159
586 BRONCHIECTASIS 158
587 DIALYSIS 158
588 LUPUS NEPHRITIS 158
589 SKIN MASS 158
590 HYPERLIPIDAEMIA 157
591 TOXIC ENCEPHALOPATHY 157
592 LIVER TRANSPLANT 156
593 MIGRAINE 156
594 PAPULE 156
595 RENAL CELL CARCINOMA 156
596 ULCER 156
597 AMNESIA 155
598 EOSINOPHILIA 155
599 HYPERTROPHIC CARDIOMYOPATHY 155
600 NEUTROPHIL COUNT DECREASED 155
601 NEW ONSET DIABETES AFTER TRANSPLANTATION 155
602 ARTHRITIS 154
603 COGNITIVE DISORDER 154
604 HYPOCALCAEMIA 154
605 PYELONEPHRITIS ACUTE 154
606 RASH MACULAR 154
607 IRON DEFICIENCY ANAEMIA 153
608 LEFT VENTRICULAR HYPERTROPHY 153
609 MALIGNANT MELANOMA 152
610 POST TRANSPLANT DISTAL LIMB SYNDROME 152
611 INFECTIOUS PLEURAL EFFUSION 151
612 MUSCULOSKELETAL STIFFNESS 151
613 GINGIVAL HYPERTROPHY 150
614 HYPERVOLAEMIA 150
615 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 150
616 BLOOD CREATININE ABNORMAL 149
617 GRAFT VERSUS HOST DISEASE IN LUNG 149
618 HEPATIC STEATOSIS 149
619 HEPATITIS CHOLESTATIC 149
620 HYPERURICAEMIA 148
621 MYCOBACTERIUM ABSCESSUS INFECTION 148
622 FLUID OVERLOAD 147
623 GRANULOMA 147
624 METASTASES TO LYMPH NODES 147
625 SKIN BURNING SENSATION 147
626 DIARRHOEA HAEMORRHAGIC 146
627 ARRHYTHMIA 145
628 HYPERTRIGLYCERIDAEMIA 145
629 MYOSITIS 145
630 ODYNOPHAGIA 145
631 SKIN PLAQUE 145
632 ADRENAL INSUFFICIENCY 144
633 GENERALISED OEDEMA 144
634 SKIN NECROSIS 144
635 GASTROINTESTINAL TOXICITY 143
636 HISTIOCYTOSIS HAEMATOPHAGIC 143
637 ANGIOEDEMA 142
638 DRY MOUTH 142
639 THROMBOTIC THROMBOCYTOPENIC PURPURA 142
640 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 142
641 THERAPY CESSATION 141
642 HAEMODIALYSIS 140
643 HALLUCINATION 140
644 HERPES VIRUS INFECTION 140
645 INTENTIONAL PRODUCT MISUSE 140
646 HEPATIC NECROSIS 139
647 IMMUNODEFICIENCY 139
648 HAEMATOLOGICAL INFECTION 138
649 ILEUS 138
650 MENINGITIS 137
651 RENAL ARTERY STENOSIS 137
652 MENTAL DISORDER 136
653 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 136
654 B-CELL LYMPHOMA 135
655 BALANCE DISORDER 135
656 BLOOD CHOLESTEROL INCREASED 135
657 COMPLICATIONS OF TRANSPLANTED LUNG 135
658 LUNG NEOPLASM MALIGNANT 135
659 MASS 135
660 MYCOPLASMA INFECTION 135
661 BLOOD ALBUMIN DECREASED 134
662 CARDIOMYOPATHY 134
663 CIRCULATORY COLLAPSE 134
664 CORONAVIRUS INFECTION 134
665 INFLUENZA LIKE ILLNESS 134
666 AUTOIMMUNE HEPATITIS 133
667 STEROID DIABETES 133
668 STRESS 133
669 ENGRAFTMENT SYNDROME 132
670 MICROSPORIDIA INFECTION 132
671 MYASTHENIA GRAVIS 132
672 ACCIDENTAL EXPOSURE TO PRODUCT 131
673 ENTEROCOCCAL BACTERAEMIA 131
674 INJECTION SITE SWELLING 131
675 SUBCUTANEOUS ABSCESS 131
676 UNEVALUABLE EVENT 131
677 ABDOMINAL PAIN LOWER 130
678 ATYPICAL MYCOBACTERIAL INFECTION 130
679 BLOOD CREATINE INCREASED 130
680 CHRONIC MYELOID LEUKAEMIA 130
681 INTRACRANIAL PRESSURE INCREASED 130
682 METASTASES TO BONE 130
683 NEUTROPHIL COUNT INCREASED 130
684 UREAPLASMA INFECTION 130
685 UVEITIS 130
686 BLOOD MAGNESIUM DECREASED 129
687 BRAIN HERNIATION 129
688 CATATONIA 129
689 CEREBRAL ASPERGILLOSIS 129
690 HYPERPARATHYROIDISM SECONDARY 129
691 NEPHROGENIC ANAEMIA 129
692 NASAL CONGESTION 128
693 OPPORTUNISTIC INFECTION 128
694 PULMONARY FIBROSIS 128
695 ENTEROVIRUS INFECTION 127
696 PARAINFLUENZAE VIRUS INFECTION 127
697 PERITONITIS BACTERIAL 127
698 POTENTIATING DRUG INTERACTION 127
699 WOUND DEHISCENCE 127
700 HALLUCINATION, VISUAL 126
701 NIGHT SWEATS 126
702 OSMOTIC DEMYELINATION SYNDROME 126
703 TRANSITIONAL CELL CARCINOMA 126
704 ISCHAEMIC STROKE 125
705 LABORATORY TEST ABNORMAL 125
706 CAT SCRATCH DISEASE 124
707 GRAFT COMPLICATION 124
708 NEUTROPENIC SEPSIS 124
709 RENAL TUBULAR DISORDER 124
710 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 124
711 UNRESPONSIVE TO STIMULI 124
712 HEPATIC ENCEPHALOPATHY 123
713 IMMUNE THROMBOCYTOPENIA 123
714 PNEUMONIA VIRAL 123
715 PROTEIN URINE PRESENT 123
716 UPPER GASTROINTESTINAL HAEMORRHAGE 123
717 LOCALISED INFECTION 122
718 POST PROCEDURAL COMPLICATION 122
719 DEPRESSED MOOD 121
720 EYE DISORDER 121
721 INTRAOCULAR PRESSURE INCREASED 121
722 URETERIC STENOSIS 121
723 CLOSTRIDIAL INFECTION 120
724 FUSARIUM INFECTION 120
725 GASTROINTESTINAL INFECTION 120
726 HAEMORRHOIDS 120
727 ILL-DEFINED DISORDER 120
728 LEUKOENCEPHALOPATHY 120
729 CEREBRAL NOCARDIOSIS 119
730 CYSTITIS VIRAL 119
731 IMMUNE SYSTEM DISORDER 119
732 LARGE INTESTINAL ULCER 119
733 OESOPHAGEAL STENOSIS 119
734 SKIN IRRITATION 119
735 THERAPEUTIC PRODUCT EFFECT DECREASED 119
736 TUMOUR LYSIS SYNDROME 119
737 VASCULITIS 119
738 ABDOMINAL INFECTION 118
739 CENTRAL NERVOUS SYSTEM LYMPHOMA 118
740 FAILURE TO THRIVE 118
741 HYPOVOLAEMIA 118
742 INJECTION SITE ERYTHEMA 118
743 PRODUCT SUBSTITUTION ISSUE 118
744 ATAXIA 117
745 FLUSHING 117
746 HYPOPHOSPHATAEMIA 117
747 PRODUCT PRESCRIBING ERROR 117
748 TYPE 2 DIABETES MELLITUS 117
749 CENTRAL NERVOUS SYSTEM INFECTION 116
750 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 116
751 GLOMERULONEPHRITIS MEMBRANOUS 116
752 MITRAL VALVE INCOMPETENCE 116
753 MYOCARDITIS 116
754 PNEUMOPERITONEUM 116
755 PORTAL VEIN THROMBOSIS 116
756 VISCERAL LEISHMANIASIS 116
757 BLOOD PRESSURE SYSTOLIC INCREASED 115
758 DRUG LEVEL FLUCTUATING 115
759 CORONARY ARTERY DISEASE 114
760 CUSHINGOID 114
761 MONKEYPOX 114
762 VARICELLA 114
763 VENTRICULAR TACHYCARDIA 114
764 BLOOD PRESSURE FLUCTUATION 113
765 HYPERTRANSAMINASAEMIA 113
766 NEUROLOGICAL SYMPTOM 113
767 PULMONARY TOXICITY 113
768 HYDROCEPHALUS 112
769 SOFT TISSUE INFECTION 112
770 CHOLELITHIASIS 111
771 CYTOMEGALOVIRUS ENTERITIS 111
772 MYOCLONUS 111
773 OPTIC NEUROPATHY 111
774 PANCREAS TRANSPLANT REJECTION 111
775 BILE DUCT STENOSIS 110
776 ABDOMINAL ABSCESS 109
777 PRODUCT DOSE OMISSION IN ERROR 109
778 FUNGAEMIA 108
779 HAEMATOTOXICITY 108
780 HEPATITIS B REACTIVATION 108
781 HEPATOMEGALY 108
782 SPEECH DISORDER 108
783 STREPTOCOCCAL INFECTION 108
784 BLOOD TRIGLYCERIDES INCREASED 107
785 GLOMERULOSCLEROSIS 107
786 MEDICATION ERROR 107
787 BONE PAIN 106
788 INFECTIVE ANEURYSM 106
789 RECTAL HAEMORRHAGE 106
790 RHODOCOCCUS INFECTION 106
791 CACHEXIA 105
792 CARDIAC FAILURE ACUTE 105
793 CORYNEBACTERIUM INFECTION 105
794 MYOCARDIAL ISCHAEMIA 105
795 ACCIDENTAL OVERDOSE 104
796 ARTHRITIS BACTERIAL 104
797 BODY TEMPERATURE INCREASED 104
798 BURKITT^S LYMPHOMA 104
799 EMPYEMA 104
800 ENTEROCOCCAL SEPSIS 104
801 HAEMATEMESIS 104
802 CARDIOMEGALY 103
803 GLYCOSYLATED HAEMOGLOBIN INCREASED 103
804 GOUT 103
805 NORMOCYTIC ANAEMIA 103
806 PORTAL HYPERTENSION 103
807 ADVERSE EVENT 102
808 AZOTAEMIA 102
809 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 102
810 EMOTIONAL DISTRESS 102
811 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 102
812 RETINAL HAEMORRHAGE 102
813 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 102
814 DISSEMINATED ASPERGILLOSIS 101
815 INFECTION IN AN IMMUNOCOMPROMISED HOST 101
816 INFLAMMATORY MARKER INCREASED 101
817 NORMAL NEWBORN 101
818 DERMATOPHYTOSIS 100
819 DISTURBANCE IN ATTENTION 100
820 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 100
821 KLEBSIELLA SEPSIS 100
822 ABSCESS LIMB 99
823 EPSTEIN-BARR VIRUS TEST POSITIVE 99
824 HEPATOSPLENOMEGALY 99
825 LUNG OPACITY 99
826 METASTASIS 99
827 MUSCULOSKELETAL PAIN 99
828 MYCOBACTERIUM HAEMOPHILUM INFECTION 99
829 NODULE 99
830 BLOOD IMMUNOGLOBULIN G DECREASED 98
831 CYTOMEGALOVIRUS OESOPHAGITIS 98
832 DRUG DOSE OMISSION 98
833 MOBILITY DECREASED 98
834 POLYURIA 98
835 PROSTATE CANCER 98
836 SUICIDAL IDEATION 98
837 DYSGEUSIA 97
838 ILEAL ULCER 97
839 IRRITABILITY 97
840 NEPHRITIS 97
841 OSTEOPENIA 97
842 PNEUMONIA STAPHYLOCOCCAL 97
843 VASCULAR PSEUDOANEURYSM 97
844 ABORTION INDUCED 96
845 ANGIOSARCOMA 96
846 ANOGENITAL WARTS 96
847 BLOOD SODIUM DECREASED 96
848 CARDIOVASCULAR DISORDER 96
849 ANGINA PECTORIS 95
850 HUMAN EHRLICHIOSIS 95
851 PARALYSIS 95
852 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 94
853 DIFFUSE ALVEOLAR DAMAGE 94
854 DUODENAL ULCER 94
855 FEELING HOT 94
856 INTERNATIONAL NORMALISED RATIO INCREASED 94
857 WHEEZING 94
858 AGGRESSION 93
859 HUMAN HERPESVIRUS 6 ENCEPHALITIS 93
860 LUNG ABSCESS 93
861 PERICARDITIS 93
862 POLLAKIURIA 93
863 PRODUCT DOSE OMISSION 93
864 PRODUCT QUALITY ISSUE 93
865 PROTEUS INFECTION 93
866 CARDIAC TAMPONADE 92
867 MYCOBACTERIUM CHELONAE INFECTION 92
868 PULSELESS ELECTRICAL ACTIVITY 92
869 RALES 92
870 VASCULAR DEVICE INFECTION 92
871 VENTRICULAR SEPTAL DEFECT 92
872 DYSPHONIA 91
873 HYPOVOLAEMIC SHOCK 91
874 NEUROENDOCRINE CARCINOMA OF THE SKIN 91
875 ACANTHAMOEBA INFECTION 90
876 APPLICATION SITE PAIN 90
877 ASPERGILLOSIS 90
878 HEART DISEASE CONGENITAL 90
879 HERPES ZOSTER DISSEMINATED 90
880 LOCKED-IN SYNDROME 90
881 PSEUDOMONAL SEPSIS 90
882 DONOR SPECIFIC ANTIBODY PRESENT 89
883 FLATULENCE 89
884 IDIOPATHIC PNEUMONIA SYNDROME 89
885 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 89
886 NECK PAIN 89
887 NECROTISING OESOPHAGITIS 89
888 SINUS TACHYCARDIA 89
889 ANOREXIA 88
890 CYTOMEGALOVIRUS GASTRITIS 88
891 DUODENITIS 88
892 EYE SWELLING 88
893 HEPATIC CYTOLYSIS 88
894 INTESTINAL ISCHAEMIA 88
895 THERAPEUTIC RESPONSE UNEXPECTED 88
896 FACIAL PARALYSIS 87
897 STREPTOCOCCAL BACTERAEMIA 87
898 SUPERINFECTION BACTERIAL 87
899 URINARY TRACT INFECTION ENTEROCOCCAL 87
900 VIRAL LOAD INCREASED 87
901 CALCINEURIN INHIBITOR INDUCED PAIN SYNDROME 86
902 LUNG TRANSPLANT 86
903 NEOPLASM PROGRESSION 86
904 NORMOCHROMIC NORMOCYTIC ANAEMIA 86
905 PRODUCT AVAILABILITY ISSUE 86
906 RESTLESSNESS 86
907 SUSPECTED OFF LABEL USE 86
908 CHOLECYSTITIS 85
909 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 85
910 ENCEPHALITIS AUTOIMMUNE 85
911 EXPOSURE VIA SKIN CONTACT 85
912 INJECTION SITE PRURITUS 85
913 METABOLIC ENCEPHALOPATHY 85
914 PSEUDOMONAL BACTERAEMIA 85
915 PSORIATIC ARTHROPATHY 85
916 SEROTONIN SYNDROME 85
917 STEM CELL TRANSPLANT 85
918 TRANSPLANTATION ASSOCIATED FOOD ALLERGY 85
919 APPENDICITIS 84
920 MEDIASTINITIS 84
921 ORAL DISORDER 84
922 PHOTOPHOBIA 84
923 PNEUMONIA PNEUMOCOCCAL 84
924 CYTOMEGALOVIRUS ENTEROCOLITIS 83
925 DERMATOMYOSITIS 83
926 EAR INFECTION 83
927 SINUSITIS FUNGAL 83
928 SKIN WEEPING 83
929 ANGIOPATHY 82
930 CYTOMEGALOVIRUS SYNDROME 82
931 DENGUE FEVER 82
932 ENTEROCOLITIS VIRAL 82
933 EPIDERMODYSPLASIA VERRUCIFORMIS 82
934 GASTROENTERITIS VIRAL 82
935 HEPATIC ARTERY THROMBOSIS 82
936 PALLOR 82
937 PAPILLOEDEMA 82
938 RASH PAPULAR 82
939 SCRATCH 82
940 SKIN HYPERPIGMENTATION 82
941 SUPRAVENTRICULAR TACHYCARDIA 82
942 URINARY INCONTINENCE 82
943 APHTHOUS ULCER 81
944 BLOOD POTASSIUM DECREASED 81
945 CALCIPHYLAXIS 81
946 COCCIDIOIDOMYCOSIS 81
947 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 81
948 DRUG ERUPTION 81
949 GESTATIONAL DIABETES 81
950 HEPATOCELLULAR INJURY 81
951 NODULAR REGENERATIVE HYPERPLASIA 81
952 NOSOCOMIAL INFECTION 81
953 PAIN OF SKIN 81
954 RENAL CYST 81
955 ASPIRATION 80
956 CONTRAINDICATED PRODUCT ADMINISTERED 80
957 DRUG TOXICITY 80
958 FISTULA 80
959 GLUCOSE TOLERANCE IMPAIRED 80
960 LEFT VENTRICULAR DYSFUNCTION 80
961 LIVE BIRTH 80
962 LOWER GASTROINTESTINAL HAEMORRHAGE 80
963 LUNG ADENOCARCINOMA 80
964 MUSCLE ATROPHY 80
965 OBSTRUCTIVE AIRWAYS DISORDER 80
966 SERUM SICKNESS 80
967 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 80
968 VENTRICULAR FIBRILLATION 80
969 DISSEMINATED BLASTOMYCOSIS 79
970 IMPAIRED GASTRIC EMPTYING 79
971 PANCREATITIS NECROTISING 79
972 PHARYNGITIS 79
973 PULMONARY CONGESTION 79
974 RENAL VEIN THROMBOSIS 79
975 SARS-COV-2 TEST POSITIVE 79
976 SUBDURAL HAEMATOMA 79
977 TRICHOSPORON INFECTION 79
978 ADENOVIRAL HEPATITIS 78
979 ILEUS PARALYTIC 78
980 INJECTION SITE REACTION 78
981 MENINGITIS BACTERIAL 78
982 PNEUMONIA INFLUENZAL 78
983 PYODERMA GANGRENOSUM 78
984 RESPIRATORY ARREST 78
985 RESTLESS LEGS SYNDROME 78
986 SCAB 78
987 TENDERNESS 78
988 TRICHOPHYTOSIS 78
989 BLOOD CREATINE PHOSPHOKINASE INCREASED 77
990 CHOROIDITIS 77
991 FUNGAL ENDOCARDITIS 77
992 NECROTISING RETINITIS 77
993 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 77
994 PROSTATITIS 77
995 TRUNCUS ARTERIOSUS PERSISTENT 77
996 CHRONIC HEPATITIS 76
997 GASTROINTESTINAL MUCORMYCOSIS 76
998 HAEMOTHORAX 76
999 LARGE INTESTINE POLYP 76